Atea Pharmaceuticals, Inc. ( NASDAQ:AVIR – Get Rating ) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 1,870,000 shares, a growth of 9.4% from the May 15th total of 1,710,000 shares. Approximately 2.6% of the company's stock are short sold. Based on an average daily volume of 816,700 shares, the days-to-cover ratio is currently 2.3 days. Atea Pharmaceuticals Price Performance AVIR traded down $0.03 during mid-day trading on Friday, reaching $4.
https://www.dailypolitical.com/2023/06/18/atea-pharmaceuticals-inc-nasdaqavir-short-interest-up-9-4-in-may.html#dailypolitical
Sinun täytyy kirjautua sisään ennen kuin voit kommentoida.